Energy

Gender diversity and economic growth

Most macroeconomic and growth accounting models assume that male and female workers are perfectly substitutable in the aggregate production function. Whether this assumption is valid is an empirical question that this paper aims to answer by estimating the elasticity of substitution between female and male labour. We apply linear and non-linear techniques to firm-level data, cross-country sectoral data and cross-country aggregate data. We find that women and men are far from being perfect substitutes in production, a result that is consistent with much microeconomic evidence, but has not permeated to macroeconomics. The failure to account for imperfect gender substitutability has far-reaching implications. In particular, standard growth accounting exercises are likely to attribute to technological progress gains that are more properly attributable to the impact of greater gender inclusiveness in the labour force over time. Put differently, the gains from gender inclusiveness are likely to be much larger than standard economic models estimate.

GLOBAL BUSINESS AND FINANCE MAGAZINE

Recent Posts

IMF strategy chief urges countries to maintain price stability

Christian Mumssen, the fund's new director of ​strategy, cited a rapid succession of major shocks…

22 hours ago

Gold bounces from two-week low, markets await US inflation data

Gold bounces from two-week low, markets await US inflation data. Gold ticked higher on Tuesday…

22 hours ago

Dollar dips ahead of US inflation data, supported by rate outlook

Reuters poll forecasts U.S. headline inflation at 3.8%.  The dollar remained in sight of 13-month…

22 hours ago

After Credit Suisse, markets find bail-in less credible

When Credit Suisse failed in March 2023, Swiss authorities, against market expectations, set aside the…

24 hours ago

Higher utilisation explains the recent surge in productivity growth

US labour productivity has accelerated since 2022. Output per hour grew around 2.5% per year…

1 day ago

Harmonising access and reinventing the procurement of innovative medicines in Europe

Europe pays for innovative medicines through 27 uncoordinated national negotiations, generating access delays, cross-country pricing…

2 days ago